HAPPLYZ Medical joins the IN CITU France 2030 experimentation hub

A new turning point for HAPPLYZ Medical in 2025!

Our team is very proud to have been selected as one of the 3 winning projects joining the IN CITU experimentation hub (Tiers-Lieu d'Expérimentation). This programme is one of the 37 experimentation hubs approved under the France 2030 programme, funded by the Caisse des Dépôts group.

The goal? To bring forward innovative digital health solutions that improve patient follow-up and medical organisation across the region.

Thanks to this opportunity, our LORIO solution is going to reach a new milestone! We will assess, in an experimental setting, the impact of our fun, connected respiratory rehabilitation solution on improving the remote monitoring of patients with chronic respiratory failure. This is a major issue, particularly in our Hauts-de-France region, where needs are high because of the prevalence of the condition and disparities in medical coverage.

We are joining a consortium of committed partners: Lille University Hospital, Eurasanté, URPS Médecins libéraux des Hauts-de-France, the University of Lille and the Compagnie des Tiers-Lieux. Together with these key regional players, we will bring this project to life and strengthen access to digital care for all.

We would like to take this opportunity to thank all the partners, organisations and early adopters who have supported us since the beginning of the adventure. It is also thanks to them that LORIO can keep evolving and have a positive impact on our users' health.

A big thank you to you all 🙏